Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trane Technologies
TT
|
+$169M |
| 2 |
AbbVie
ABBV
|
+$155M |
| 3 |
Otis Worldwide
OTIS
|
+$127M |
| 4 |
Blackrock
BLK
|
+$110M |
| 5 |
Alibaba
BABA
|
+$109M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$372M |
| 2 |
RTN
Raytheon Company
RTN
|
+$235M |
| 3 |
Apple
AAPL
|
+$143M |
| 4 |
Microsoft
MSFT
|
+$90.5M |
| 5 |
McDonald's
MCD
|
+$56.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.87% |
| 2 | Healthcare | 13.29% |
| 3 | Financials | 12.68% |
| 4 | Consumer Discretionary | 11.36% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
2176
DELISTED
Revance Therapeutics, Inc.
RVNC
| $485K | ﹤0.01% |
19,871
+807
| +4% | +$15.9K |
|
2177
Atkore
ATKR
$3.16B
| $482K | ﹤0.01% |
17,624
+1,352
| +8% | +$33.4K |
|
|
SWAV
2178
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $480K | ﹤0.01% |
10,143
+6,016
| +146% | +$248K |
|
2179
Cato Corp
CATO
$66.1M
| $478K | ﹤0.01% |
58,441
+2,422
| +4% | +$23.9K |
|
2180
Codexis
CDXS
$158M
| $478K | ﹤0.01% |
41,887
+19,839
| +90% | +$224K |
|
2181
Red Rock Resorts
RRR
$3.62B
| $477K | ﹤0.01% |
43,744
-986
| -2% | -$11.1K |
|
2182
PLDT
PHI
$4.33B
| $476K | ﹤0.01% |
19,486
-1,320
| -6% | -$31.4K |
|
|
VIE
2183
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $474K | ﹤0.01% |
10,944
+10,149
| +1,277% | +$460K |
|
|
TMUSR
2184
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
| $472K | ﹤0.01% |
+2,917,187
| New | +$819K |
|
2185
Team
TISI
$77.7M
| $467K | ﹤0.01% |
8,393
+517
| +7% | +$28.6K |
|
|
KRTX
2186
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $466K | ﹤0.01% |
4,187
+2,557
| +157% | +$222K |
|
|
ZUO
2187
DELISTED
Zuora, Inc.
ZUO
| $463K | ﹤0.01% |
36,318
+4,971
| +16% | +$55.4K |
|
2188
Domo
DOMO
$184M
| $462K | ﹤0.01% |
14,355
+1,237
| +9% | +$27.5K |
|
2189
York Water
YORW
$514M
| $459K | ﹤0.01% |
9,571
+992
| +12% | +$43K |
|
|
PRNB
2190
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $458K | ﹤0.01% |
7,674
+3,971
| +107% | +$245K |
|
2191
TG Therapeutics
TGTX
$7.62B
| $457K | ﹤0.01% |
23,475
+1,800
| +8% | +$29K |
|
2192
Cars.com
CARS
$660M
| $455K | ﹤0.01% |
79,120
+4,203
| +6% | +$23.2K |
|
2193
Spok Holdings
SPOK
$241M
| $455K | ﹤0.01% |
48,740
+2,825
| +6% | +$29.3K |
|
2194
American Coastal Insurance
ACIC
$493M
| $451K | ﹤0.01% |
57,582
+3,834
| +7% | +$31.1K |
|
|
MAXR
2195
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $449K | ﹤0.01% |
24,997
+199
| +0.8% | +$2.57K |
|
|
BRSP
2196
BrightSpire Capital
BRSP
$648M
| $448K | ﹤0.01% |
63,759
+607
| +1% | +$3.11K |
|
|
DRNA
2197
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $448K | ﹤0.01% |
17,645
+2,088
| +13% | +$45K |
|
2198
Daktronics
DAKT
$1.04B
| $447K | ﹤0.01% |
102,855
+5,225
| +5% | +$23.1K |
|
2199
Liquidity Services
LQDT
$1.32B
| $443K | ﹤0.01% |
74,276
+6,006
| +9% | +$31.9K |
|
2200
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $436K | ﹤0.01% |
22,063
-1,069
| -5% | -$21.2K |
|
Similar funds
Legal & General Group's Q2 2020 Portfolio in Review
As of Q2 2020, Legal & General Group held 3,579 positions worth $207B, up 21% from $171B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Legal & General Group's Q2 2020 filing shows 222 new, 1,974 increased, 815 reduced and 175 closed positions. Its largest new stake was Otis Worldwide: 2,441,915 shares worth $139M. The largest sale was Allergan plc, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Legal & General Group's largest Q2 2020 buy was Otis Worldwide: 2,441,915 shares worth $139M.
- Legal & General Group added most to Trane Technologies in Q2 2020, an estimated $169M increase.
- Legal & General Group's biggest Q2 2020 reduction was Apple, cutting an estimated $143M.
- Legal & General Group fully exited Allergan plc in Q2 2020, selling an estimated $372M.
- Legal & General Group's ten largest holdings make up 21% of its $207B portfolio in Q2 2020.
- Legal & General Group opened 222 new positions and closed 175 in Q2 2020.
- Legal & General Group's portfolio value rose 21% quarter-over-quarter to $207B.
Based on Legal & General Group's 13F filing for Q2 2020, filed 14 Aug 2020.